Janux Therapeutics Inc (JANX) Insider Trading
- $11,156,442.66
- $182,107,978.93
- Sept. 30, 2024
- Ventures Xi L.P. Avalon
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | Major Shareholder | 958 | $46.24 | Sell | $44,297.92 | |
| Sept. 27, 2024 | Major Shareholder | 49,231 | $46.45 | Sell | $2,286,779.95 | |
| Sept. 27, 2024 | Insider | 50,000 | $45.96 | Sell | $2,298,000.00 | |
| Sept. 27, 2024 | CEO | 25,000 | $46.31 | Sell | $1,157,750.00 | |
| Sept. 12, 2024 | Major Shareholder | 158,031 | $47.00 | Sell | $7,427,457.00 | |
| Sept. 9, 2024 | Major Shareholder | 2,182 | $42.33 | Sell | $92,364.06 | |
| Sept. 6, 2024 | Major Shareholder | 108,365 | $42.00 | Sell | $4,551,330.00 | |
| June 3, 2024 | Director | 1,500,000 | $54.75 | Sell | $82,125,000.00 | |
| June 3, 2024 | CFO | 822,721 | $54.75 | Sell | $45,043,974.75 | |
| June 3, 2024 | Major Shareholder | 677,279 | $54.75 | Sell | $37,081,025.25 | |
| Nov. 13, 2023 | Major Shareholder | 849,854 | $5.87 | Buy | $4,988,642.98 | |
| July 19, 2023 | Director | 495,008 | $12.46 | Buy | $6,167,799.68 |
Insiders are both buying and selling Janux Therapeutics Inc stock.
The insider traders at Janux Therapeutics Inc are: Ventures Xi L.P. Avalon, Andrew Hollman Meyer, David Alan Campbell, Jay Lichter, Ra Capital Management, L.P., and Tighe Reardon
The most active insider trader at Janux Therapeutics Inc is Ventures Xi L.P. Avalon with 7 trades.
Jay Lichter has sold the most Janux Therapeutics Inc stock with a total value of $164,250,000.00.
Ra Capital Management, L.P. has bought the most Janux Therapeutics Inc stock with a total value of $12,335,599.36.
The most recent insider trade for Janux Therapeutics Inc was on Sept. 30, 2024.
The single biggest insider buy for Janux Therapeutics Inc was from Ra Capital Management, L.P. with a total value of $6,167,799.68 on July 19, 2023.
The single biggest insider sell for Janux Therapeutics Inc was from Jay Lichter with a total value of $82,125,000.00 on June 3, 2024.